Researchers have compiled and analysed 115 years of malaria data in Africa, providing the most detailed picture yet of where efforts to control malaria infection are being won and lost across the continent.
A global conference in October will accelerate action on tackling drug-resistant infections, one of the greatest health and economic challenges of our time.
The G20 summit starts today in Hamburg. Jeremy Farrar, Wellcome's Director, and Paul Stoffels, Chief Scientific Officer of Johnson & Johnson, urge them to keep up the momentum in tackling infectious disease outbreaks.
In an open letter, our Director Jeremy Farrar congratulates the new head of the World Health Organization Tedros Adhanom Ghebreyesus, and sets out what Wellcome thinks the WHO's priorities should be.
This week marks a year since the publication of the International Review on Antimicrobial Resistance, a review led by Lord Jim O’Neill and supported by Wellcome.
Wellcome is joining international experts to call for a review of the global language used to discuss the problem of pathogens resistant to available drugs.
Whole Genome Sequencing is being used to identify tuberculosis (TB), improving treatment for patients and helping stem the spread of drug-resistant infections.